FDA’s Drug Industry Fees Fuel Concerns Over Influencenews2022-09-15T09:00:26+00:00September 15th, 2022|The New York Times|
With Biden’s Agenda in the Balance, Lobbying Kicks Into High Gearnews2021-10-05T00:38:57+00:00October 5th, 2021|The New York Times|
Democrats’ Stumble on Drug Prices Shows Power of Industrynews2021-09-15T22:28:33+00:00September 15th, 2021|The New York Times|
BioBonds Use Wall Street Tools to Fund Medical Researchnews2021-07-12T10:47:53+00:00July 12th, 2021|The New York Times|
